MedTrace Logo

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

NCT06115122 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-08-05

No results posted yet for this study

Summary

The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population.

Condition or disease: pre-eclampsia, intrauterine growth restriction, polycystic ovary syndrome

Conditions

  • Pre-Eclampsia
  • Intrauterine Growth Restriction
  • Polycystic Ovary Syndrome
  • Iron-deficiency
  • Cardiovascular Diseases
  • Hypertensive Disorder of Pregnancy
  • Proteinuria in Pregnancy

Interventions

OTHER

Pre-eclampsia screening program

Pregnant women will be devided into risk-, control- and PCOS groups according to first trimester screening program.

Sponsors & Collaborators

  • PerkinElmer, Inc.

    collaborator INDUSTRY

  • Roche Diagnostics GmbH

    collaborator INDUSTRY

  • Academy of Finland

    collaborator OTHER

  • Sigrid Jusélius Foundation

    collaborator OTHER

  • Finnish Medical Foundation

    collaborator NETWORK

  • University of Oulu

    collaborator OTHER

  • Oulu University Hospital

    lead OTHER

Principal Investigators

  • Jaana Nevalainen, Assoc prof · The Wellbeing Services County of North Ostrobothnia

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2027-12-31
Completion
2041-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06115122 on ClinicalTrials.gov